Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Journal of Computer-Aided Molecular Design
|
October 10, 2014
Seeking potential anticonvulsant agents that target GABAA receptors using experimental and theoretical procedures
Margarita Virginia Saavedra-Vélez, José Correa-Basurto, Myrna H Matus, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
November 20, 2018
Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER
Oscar J Zacarías-Lara, David Méndez-Luna, Gustavo Martínez-Ruíz, et al.
The Journal of Pharmacy and Pharmacology
|
April 21, 2020
Exploring the biotransformation of N-(2-hydroxyphenyl)-2-propylpentanamide (an aryl valproic acid derivative) by CYP2C11, using in silico predictions and in vitro studies
Jessica Elena Mendieta-Wejebe, Arianna Silva-Trujillo, Martiniano Bello, et al.
Journal of Biomolecular Structure & Dynamics
|
March 12, 2020
Fucosterol from <i>Sargassum horridum</i> as an amyloid-beta (Aβ<sub>1-42</sub>) aggregation inhibitor: <i>in vitro</i> and <i>in silico</i> studies
Elena Sthephanie Castro-Silva, Martiniano Bello, Martha Cecilia Rosales-Hernández, et al.
Biomolecules
|
May 4, 2026
Aryl-Boroxazolidones with Low In Vitro Neurotoxicity and Alleviative Effects on MPTP-Induced Parkinsonism in Mice
Antonio Abad-García, Martiniano Bello, Maricarmen Hernández-Rodríguez, et al.
BMC Cancer
|
November 2, 2018
The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo
Pedro Cruz-Nova, Michael Schnoor, José Correa-Basurto, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
May 11, 2018
Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells
Alberto Martínez-Muñoz, Berenice Prestegui-Martel, David Méndez-Luna, et al.
Molecules (Basel, Switzerland)
|
September 9, 2022
<sup>131</sup>I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B-PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer-Biological Characterization, Biokinetics and Dosimetry
Pedro Cruz-Nova, Blanca Ocampo-García, Dayan Andrea Carrión-Estrada, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 13, 2021
Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells
David Méndez-Luna, Loreley Araceli Morelos-Garnica, Juan Benjamín García-Vázquez, et al.
Frontiers in Oncology
|
April 4, 2024
Antineoplastic effect of compounds C14 and P8 on TNBC and radioresistant TNBC cells by stabilizing the K-Ras4B<sup>G13D</sup>/PDE6δ complex
Dayan A Carrión-Estrada, Arturo Aguilar-Rojas, Sara Huerta-Yepez, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Journal of Computer-Aided Molecular Design
|
October 10, 2014
Seeking potential anticonvulsant agents that target GABAA receptors using experimental and theoretical procedures
Margarita Virginia Saavedra-Vélez, José Correa-Basurto, Myrna H Matus, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
November 20, 2018
Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER
Oscar J Zacarías-Lara, David Méndez-Luna, Gustavo Martínez-Ruíz, et al.
The Journal of Pharmacy and Pharmacology
|
April 21, 2020
Exploring the biotransformation of N-(2-hydroxyphenyl)-2-propylpentanamide (an aryl valproic acid derivative) by CYP2C11, using in silico predictions and in vitro studies
Jessica Elena Mendieta-Wejebe, Arianna Silva-Trujillo, Martiniano Bello, et al.
Journal of Biomolecular Structure & Dynamics
|
March 12, 2020
Fucosterol from <i>Sargassum horridum</i> as an amyloid-beta (Aβ<sub>1-42</sub>) aggregation inhibitor: <i>in vitro</i> and <i>in silico</i> studies
Elena Sthephanie Castro-Silva, Martiniano Bello, Martha Cecilia Rosales-Hernández, et al.
Biomolecules
|
May 4, 2026
Aryl-Boroxazolidones with Low In Vitro Neurotoxicity and Alleviative Effects on MPTP-Induced Parkinsonism in Mice
Antonio Abad-García, Martiniano Bello, Maricarmen Hernández-Rodríguez, et al.
BMC Cancer
|
November 2, 2018
The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo
Pedro Cruz-Nova, Michael Schnoor, José Correa-Basurto, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
May 11, 2018
Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells
Alberto Martínez-Muñoz, Berenice Prestegui-Martel, David Méndez-Luna, et al.
Molecules (Basel, Switzerland)
|
September 9, 2022
<sup>131</sup>I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B-PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer-Biological Characterization, Biokinetics and Dosimetry
Pedro Cruz-Nova, Blanca Ocampo-García, Dayan Andrea Carrión-Estrada, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 13, 2021
Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells
David Méndez-Luna, Loreley Araceli Morelos-Garnica, Juan Benjamín García-Vázquez, et al.
Frontiers in Oncology
|
April 4, 2024
Antineoplastic effect of compounds C14 and P8 on TNBC and radioresistant TNBC cells by stabilizing the K-Ras4B<sup>G13D</sup>/PDE6δ complex
Dayan A Carrión-Estrada, Arturo Aguilar-Rojas, Sara Huerta-Yepez, et al.
Page
of 10